BIOTRONIK announced their presentation of the one-year results from the investigator-initiated BIOPACT RCT this week
November 28, 2022
One-Year BIOPACT Randomized Controlled Trial (RCT) Results Demonstrate Excellent Results for Low-Profile Passeo-18 Lux DCB
November 28, 2022 – BIOTRONIK announced the presentation of one-year results from the investigator-initiatedBIOPACT…
Read More
Today, UltraSight announced the findings from a landmark pivotal study that confirms its AI guidance technology enables novice ultrasound users to acquire high-quality diagnostic images of the 10 standard cardiac views.
November 28, 2022
New Landmark Study Indicates UltraSight Enables Novice Ultrasound Users to Capture High Quality Cardiac Images
November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power…
Read More
Published online November 8 in the journal, Radiology, the study enabled the visualization of pulmonary hemodynamics and perfusion with high sensitivity, specificity and diagnostic accuracy, and without the use of contrast media
November 28, 2022
Study Reports Similar Efficacy of Dynamic Digital Radiography of the Chest with Lung Ventilation Perfusion for Detection of Chronic Thromboembolic Pulmonary Hypertension
November 28, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare…
Read More
Survivors face higher risk of cardiac events that can reduce their life expectancy by decades
November 25, 2022
Study Finds That Risk of Myocarditis After SARS-CoV-2 Vaccination is Increased But Very Low
November 25, 2022 —  A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger…
Read More
Left: Echocardiogram at birth shows severe non-delamination of the tricuspid valve septal leaflet, with coaptation point near the right ventricle apex (marked with arrow). The right ventricle is small, while the right atrium is large. Right: Jaxon’s echocardiogram today shows a normal tricuspid valve position (marked with arrow) and normal sizes of the right atrium and right ventricle.
November 25, 2022
From Severe Ebstein Anomaly to a Normal Heart
November 25, 2022 —  Jodie Votava-Smith, MD, has pulled up two side-by-side echocardiograms on her computer screen and…
Read More
The Cardiovascular Research Foundation has announced its Inaugural Pulse‑Setter Awards, including Pulse-setter Champion and Women as One Co-Founder, Roxana Mehran, MD.
November 23, 2022
Women as One Co-Founder Among Four to Receive Inaugural CRF Awards
November 23, 2022 — The Cardiovascular Research Foundation (CRF) has announced its inaugural Pulse‑Setter Awards,…
Read More
Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value
November 23, 2022
Viz.ai Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium
November 23, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today…
Read More
Nicholas Pajewski, Ph.D., associate professor of biostatistics and data science at Wake Forest University School of Medicine. Credit: Wake Forest University School of Medicine
November 23, 2022
Study Highlights Importance of Long-term Management of Hypertension
November 23, 2022 — In 2015, published findings from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) …
Read More
Survivors face higher risk of cardiac events that can reduce their life expectancy by decades
November 23, 2022
Exercise Testing Detects Silent Cardiovascular Dangers Common in Pediatric Cancer Survivors
November 23, 2022 — Cardiopulmonary exercise testing (CPET) can detect underlying early signs of cardiovascular…
Read More
New research by Cedars-Sinai investigators supports evidence that social factors, such as unemployment, financial difficulties, racial discrimination and other stressors, affect an individual's health. Getty Images
November 22, 2022
Racism, Stress and Stroke Outcomes
November 22, 2022 — investigators from the Department of Neurology at Cedars-Sinai have new information on stroke-…
Read More
Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options
November 22, 2022
Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population
November 22, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with…
Read More
CroĂ­Valve has announced the successful First in Human implants of its DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Poland.
November 22, 2022
CroĂ­Valve Reports Successful First in Human Implants of its DUO Tricuspid Coaptation Valve System
November 22, 2022 — CroíValve has announced the successful First in Human implants of its DUO Tricuspid Coaptation…
Read More
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo)
November 21, 2022
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
November 21, 2022 —  Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to…
Read More
UH Cleveland Medical Center. Image courtesy of University Hospitals
November 21, 2022
Four Prospective, Multicenter Studies Support Use of Drug-Coated Balloons Over Bare Metal Stents in Treating Femoropopliteal Lesions
November 21, 2022 —  New research published in the Journal of the American College of Cardiology shows the use of drug-…
Read More
Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled clinical tools have to be easily available and used.
November 21, 2022
High adopters of AI-enabled screening tool are more likely to diagnose left ventricular dysfunction than low adopters, Mayo Clinic study finds
November 21, 2022 —  Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled…
Read More
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo)
November 21, 2022
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
November 21, 2022 — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to…
Read More
Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association.
November 21, 2022
Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology
November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide,…
Read More
Justin Balko, PharmD, PhD, Ingram Associate Professor of Cancer Research, and a co-corresponding author of the study. Credit: Vanderbilt University Medical Center
November 21, 2022
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
November 22, 2022 — Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint…
Read More
Screen shots of Viz PE with RV/LV ratio data (left), along with the company’s ECG Viewer (right). Both are part of the comprehensive Viz Cardio Suite designed to speed and improve patient access to innovative cardiovascular treatments. Source: Viz.ai.
November 17, 2022
Viz.ai Launches AI-Powered Viz Cardio Suite
November 17, 2022 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination,  announced the…
Read More
Figure 1. Flow chart of machine learning workflow. A machine learning (ML) model for the prediction of vessel-specific ischemia was built, trained, and tuned in the NXT trial (Analysis of Coronary Blood Flow using CT Angiography: Next Steps). The model’s predictive performance was evaluated in the PACIFIC trial (Prospective Comparison of Cardiac Positron Emission Tomography [PET]/Computed Tomography [CT]‚ Single Photon Emission Computed Tomography [SPECT]/CT Perfusion Imaging and CT Coronary Angiography wit
November 17, 2022
AI Tool Predicts Reduced Blood Flow to the Heart
November 17, 2022 — Cedars-Sinai investigators and colleagues have developed an artificial intelligence (AI) tool that…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now